Buzz Stocks:, Inc., Cabelas Inc, and Mylan NV

Today's stocks to watch in the news include, Inc. (NASDAQ:AMZN), Cabelas Inc (NYSE:CAB), and Mylan NV (NASDAQ:MYL)

Dec 30, 2016 at 9:25 AM
facebook twitter linkedin

Heading into the last trading day of 2016, U.S. stock futures are signaling a positive open. Among specific equities in the spotlight today are online retail giant, Inc. (NASDAQ:AMZN), outdoors fanatic Cabelas Inc (NYSE:CAB), and EpiPen maker Mylan NV (NASDAQ:MYL). Here's a quick look at what's driving AMZN, CAB, and MYL.

  • AMZN is in the news this morning, thanks to reports the company -- along with Wal-Mart Stores, Inc. (NYSE:WMT) -- is being sued by the founder of music group Run-DMC for selling products related to the group without its permission. Regardless, the stock is edging higher in electronic trading, looking to add to its 13.2% year-to-date lead, last seen at $765.15. And heading into the new year, it's hard to find any skepticism directed toward, Inc. For example, 27 of 30 analysts say to buy the shares

  • CAB has slipped 7.3% in pre-market trading, after the company disclosed the Federal Trade Commission (FTC) has requested additional information (subscription required) related to its planned merger with Bass Pro Shops. However, the company still says it plans to be cleared by U.S. and Canadian regulators in the first half of 2017. The stock has been hovering just beneath Bass Pro Shops' takeover offer of $65.50 per share in recent weeks, finishing Thursday at $61.68. If the pre-market losses come to fruition, Cabelas Inc would open at $57.20 -- still higher than where it was trading before the merger was announced, but also representing the stock's largest percentage drop in 10 months. 

  • MYL has added 2.2% ahead of the open, after the drugmaker announced it's launching a generic version of Johnson & Johnson's (NYSE:JNJ) Concerta. The stock needs the boost, as its failed to recover from the EpiPen drama that sent the shares stumbling back in August, with MYL closing Thursday at $37.38. Even so, analysts have remained bullish on Mylan NV. At the moment, seven brokerage firms say the stock is a "strong buy," while zero have issued "sell" ratings. 

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners